VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

iwCLL 2019 | Relevance of prognostic factors in the era of targeted therapies in CLL

Adam Kittai, MD, Ohio State University, Columbus, OH discusses his recently published review in Current Hematologic Malignancy Reports on the relevance of prognostic factors in the era of targeted therapies in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter